For example, lactylation of IGF2BP3 ultimately drives the reprogramming of serine metabolism in HCC and ultimately contributes to Lenvatinib resistance (Lu et al. 2024). This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.